- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 453/06 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing iso-quinuclidine ring systems
Patent holdings for IPC class C07D 453/06
Total number of patents in this class: 69
10-year publication summary
|
6
|
5
|
5
|
4
|
5
|
3
|
0
|
7
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Demerx, Inc. | 74 |
9 |
| The University of Melbourne | 522 |
4 |
| Philip Morris Products S.A. | 7282 |
3 |
| Achillion Pharmaceuticals, Inc. | 168 |
3 |
| Boehringer Ingelheim International GmbH | 4756 |
2 |
| The Trustees of Columbia University in the City of New York | 3518 |
2 |
| Banyu Pharmaceutical Co., Ltd. | 84 |
2 |
| Heptares Therapeutics Limited | 118 |
2 |
| MSD K.K. | 75 |
2 |
| Rottapharm Biotech S.r.l. | 43 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3038 |
2 |
| Aligos Therapeutics, Inc. | 144 |
2 |
| Nxera Pharma UK Limited | 119 |
2 |
| Bristol-myers Squibb Company | 4883 |
1 |
| F. Hoffmann-La Roche AG | 7939 |
1 |
| Hoffmann-La Roche Inc. | 3255 |
1 |
| AstraZeneca AB | 2961 |
1 |
| AstraZeneca UK Limited | 702 |
1 |
| Janssen Pharmaceutica N.V. | 3624 |
1 |
| Bayer AG | 3206 |
1 |
| Other owners | 25 |